keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Citrullinated LL-37 3cit, a modified form of the LL-37 peptide, exhibits no antiviral activity at a concentration of 10 μg/mL while maintaining partial efficacy against HRV at 30 μg/mL. Furthermore, this citrullinated variant demonstrates diminished immunomodulatory properties compared to the native LL-37 and a moderate reduction in its capacity to decrease HRV-induced CCL5 secretion [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Citrullinated LL-37 3cit, a modified form of the LL-37 peptide, exhibits no antiviral activity at a concentration of 10 μg/mL while maintaining partial efficacy against HRV at 30 μg/mL. Furthermore, this citrullinated variant demonstrates diminished immunomodulatory properties compared to the native LL-37 and a moderate reduction in its capacity to decrease HRV-induced CCL5 secretion [1]. |
Molecular Weight | 4497.2 |
Formula | C205H336N56O57 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Citrullinated LL-37 4cit inhibitor inhibit